232 related articles for article (PubMed ID: 25040579)
1. Proteomics for the diagnosis of thyroid lesions: preliminary report.
Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.
Pagni F; De Sio G; Garancini M; Scardilli M; Chinello C; Smith AJ; Bono F; Leni D; Magni F
Proteomics; 2016 Jun; 16(11-12):1775-84. PubMed ID: 27029406
[TBL] [Abstract][Full Text] [Related]
3. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
4. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
5. Analytical Performance of a Gene Expression Classifier for Medullary Thyroid Carcinoma.
Pankratz DG; Hu Z; Kim SY; Monroe RJ; Wong MG; Traweek ST; Kloos RT; Walsh PS; Kennedy GC
Thyroid; 2016 Nov; 26(11):1573-1580. PubMed ID: 27605259
[TBL] [Abstract][Full Text] [Related]
6. Fine-Needle Aspiration with Immunohistochemistry Using a Modified Scrape Cell Block Technique for the Diagnosis of Thyroid and Parathyroid Nodules.
Wuertz FG; Kresnik E; Malle P; Hyden M; Lind P; Rogatsch H; Gallowitsch HJ
Acta Cytol; 2016; 60(2):118-30. PubMed ID: 27231232
[TBL] [Abstract][Full Text] [Related]
7. MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.
Mosele N; Smith A; Galli M; Pagni F; Magni F
Methods Mol Biol; 2017; 1618():37-47. PubMed ID: 28523498
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison.
Piga I; Capitoli G; Clerici F; Mahajneh A; Brambilla V; Smith A; Leni D; L'Imperio V; Galimberti S; Pagni F; Magni F
Anal Bioanal Chem; 2021 Feb; 413(5):1259-1266. PubMed ID: 33277997
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of new biomarkers and application in thyroid cytology.
Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
[TBL] [Abstract][Full Text] [Related]
10. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
11. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies.
Adhikari LJ; Sciallis AP; Reynolds J; Jenkins S; Smith C; Stan MN; Nassar A
Thyroid; 2013 Aug; 23(8):982-8. PubMed ID: 23374006
[TBL] [Abstract][Full Text] [Related]
13. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
[TBL] [Abstract][Full Text] [Related]
14. Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions.
Piga I; Casano S; Smith A; Tettamanti S; Leni D; Capitoli G; Pincelli AI; Scardilli M; Galimberti S; Magni F; Pagni F
Expert Rev Proteomics; 2018 Nov; 15(11):937-948. PubMed ID: 30290700
[TBL] [Abstract][Full Text] [Related]
15. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
16. Mixed medullary-follicular carcinoma of the thyroid: diagnostic dilemmas in fine-needle aspiration cytology.
Hanna AN; Michael CW; Jing X
Diagn Cytopathol; 2011 Nov; 39(11):862-5. PubMed ID: 21994201
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.
Brown LM; Helmke SM; Hunsucker SW; Netea-Maier RT; Chiang SA; Heinz DE; Shroyer KR; Duncan MW; Haugen BR
Mol Carcinog; 2006 Aug; 45(8):613-26. PubMed ID: 16788983
[TBL] [Abstract][Full Text] [Related]
18. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
Elliott DD; Pitman MB; Bloom L; Faquin WC
Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
[TBL] [Abstract][Full Text] [Related]
20. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
